Wait or anticipate? The charts provide the answer.
Baxter Shareholders will also get stake in new firm Baxalta.
With 19% growth and a price-to-earnings ratio of 20, it looks cheap.
Horizon Pharma's volume trends have been very positive.
The stock is extending Friday's breakout move.
Much is working against Intuitive Surgical if support can't hold.
And it's not the favorable macroeconomic climate.
This high risk/high reward play is well off its recent highs.
Yesterday's action in UnitedHealth was a concern.
Patience called for in the biotech ETF.

Columnist Conversations

Re Yahoo
$600 million to buy market on close.
Much of what I'm hearing lately is the market is boring, it's a snooze-fest and nowhere is there a profit to b...
The Emini S&P 500 (e-SPM) and crude oil are following the same path today -- to the upside. In fact, the a...


Columnist Tweets


Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.